Train of four stimuli (TOF) is the standard of monitoring for neuromuscular blockade. Many drugs are known to alter the neuromuscular junction and the nicotinic acetylcholine receptor. Rocuronium, which has been in clinical use since 2007, shows more rapid onset than other non-depolarizing muscle relaxants. Reversal of muscle relaxant means that inhibition of acetylcholinesterase, by the administration of an anti-acetylcholinesterase, allows acetylcholine released into the synapse to remain available to bind to the acetylcholine receptor. In the near future, a new type of reversal agent, a γ-cyclodextrin (Sugammadex) , will effectively decrease the plasma concentration of available non-depolarizing neuromuscular blocking agents with a steroidal structure. This compound is water-soluble and has a hydrophobic cavity that can encapsulate steroidal neuromuscular blocking drugs, especially rocuronium. There are a lot of factors to alter neuromuscular junction, for example, which are interaction of neuromuscular blocking agents, volatile anesthetics, antibiotics, local anesthetics, diuretics, anti-convulsants, lithium, electrolytes and body temperature. The new non-depolarizing neuromuscular blocking agent, gantacurium, has a rapid onset of effect and an ultra-short duration of action.
View full abstract